According to previous reports, IDH1 mutation is common in many malignant tumors, such as glioma, acute myeloid leukemia, thyroid cancer and chondroma (Murugan et al., 2010; Amary et al., 2011; Losman et al., 2013; Bai et al., 2016). This evidence concerns the gene IDH1 and thyroid gland carcinoma.